• 12/05/2021

    Directory of TB vaccine clinical trial sites

    There are approximately 14 vaccine candidates for tuberculosis (TB). Over the upcoming 10 years these need to be tested in…

    Lees meer
  • 07/05/2021

    KNCV Nigeria won Cepheids Make it Happen Award

    KNCV Nigeria won the Cepheid Make it Happen Award for their Wellness on Wheels (WoW) project. This price…

    Lees meer
  • 24/03/2021

    Easy and child-friendly tuberculosis diagnosis in rural Ethiopia

    Mesay Gebre and her family of five live in Umiya, a mostly rural region in Ethiopia. They depend completely on…

    Lees meer
  • 18/03/2021

    Join us at the SOS Stoolbox Symposium!

    On 25 March 2021, KNCV Tuberculosis Foundation will hold a virtual symposium to celebrate the launch of the SOS Stoolbox.

    Lees meer
  • 16/03/2021

    KNCV Executive Director Mustapha Gidado: “Positive COVID test made me anxious”

    COVID19 is affecting us all, personally and professionally. Doctors, epidemiologists and infectious disease experts have also become infected and fallen…

    Lees meer
  • 08/03/2021

    TB diagnosed in time in Ethiopian family

    Selamawit, a mother of two, lives with her husband in Mole Kebele, Ethiopia. Her youngest daughter, who is now…

    Lees meer
  • 08/03/2021

    Iddirs in Ethiopia help diagnose tuberculosis in children

    In Ethiopia, female self-help associations, called “Iddirs”, help diagnose tuberculosis (TB) in children. These women receive training in which they…

    Lees meer
  • 01/02/2021

    Tell the Netherlands to invest in healthcare worldwide

    It’s become clear to everyone now; diseases know no borders. COVID-19 has shaken the whole world up about the importance…

    Lees meer
  • 22/01/2021

    Tajikistan’s tuberculosis patients receive groundbreaking new treatment

    Tajikistan is the first country in Central Asia to provide people with tuberculosis (TB)  access to  the groundbreaking new BPaL…

    Lees meer
  • 21/01/2021

    TB expert Max Meis: “My career is characterized by pandemics”

    After 11 years at KNCV Tuberculosis Foundation, Dutch TB expert Max Meis (66) is closing the virtual office door behind…

    Lees meer
  • 13/01/2021

    How digital technologies can empower patients to succeed in TB treatment

    The run-in phase of the ASCENT project has started, enrolling TB patients on digital adherence technologies in the Philippines…

    Lees meer
  • 15/12/2020

    Fear of TB infection can lead to stigma

    The recent research ‘Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the…

    Lees meer
  • 23/11/2020

    New treatment offers hope for XDR-TB patient Hanna

    Hanna from Ukraine is one of the first TB patients in the world to be treated with a new, groundbreaking…

    Lees meer
  • 23/11/2020

    Ukraine TB patients first to receive groundbreaking new drug regimen

    Ukraine is the first country in the world to provide tuberculosis (TB) patients with the groundbreaking new BPaL treatment in…

    Lees meer
  • 12/11/2020

    Smart medication container included in GDF product catalog

    Stop TB Partnership’s Global Drug Facility (GDF) and the Unitaid-funded Adherence Support Coalition to End TB (ASCENT project) announce the…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.